Fan Yan, Bai Xiaojun, Chen Yuewu, Shen Guidong, Lu Qun, Wan Zhaofei, Zhou Dong, Shen Yuan, Ma Aiqun
Department of Cardiovascular Medicine, First Affiliated Hospital of Medical College, Xi'an Jiaotong University, and Institute of Cardiovascular Channelopathy, Key Laboratory of Environment and Genes Related to Diseases of Ministry of Education, Key Laboratory of Molecular Cardiology of Shaanxi Province, Xi'an, Shaanxi, China.
Clin Cardiol. 2015 Feb;38(2):82-91. doi: 10.1002/clc.22356. Epub 2015 Feb 3.
The optimal strategy for treating late presenters of ST-elevation myocardial infarction (STEMI) remains uncertain.
percutaneous coronary intervention (PCI) has a favorable effect on left ventricular (LV) remodeling and clinical outcomes in late presenters of STEMI.
Patients with STEMI who were hospitalized between 2009 and 2011 at 7 PCI-capable hospitals in China were selected. Cardiac characteristics were reassessed by echocardiography between August 2013 and January 2014. The clinical endpoints were evaluated during a median follow-up period of 36 months.
1090 patients who either underwent late PCI (n = 786) or received standard medical therapy alone (n = 304) was analyzed. Left ventricular remodeling was more pronounced in the conservative-treatment group. Logistic regression revealed that late PCI was independently and negatively correlated with LV remodeling (odds ratio: 0.356, 95% confidence interval [CI]: 0.251-0.505, P < 0.001). Kaplan-Meier analysis showed the lower risks of major adverse cardiovascular events (MACE), all-cause death, and rehospitalization for heart failure in the late-PCI group. Multivariate Cox regression revealed that late PCI was significantly associated with lower risks for MACE, all-cause death, and rehospitalization for heart failure both in all patients (hazard ratio [HR]: 0.507, 95% CI: 0.412-0.625, P < 0.001; HR: 0.419, 95% CI: 0.314-0.559, P < 0.001; and HR: 0.583, 95% CI: 0.379-0.896, P = 0.014, respectively) and in the matched patients (HR: 0.466, 95% CI: 0.358-0.607, P < 0.001; HR: 0.398, 95% CI: 0.277-0.571, P < 0.001; and HR: 0.498, 95% CI: 0.283-0.878, P = 0.016, respectively) by propensity-score analysis.
Late-PCI strategy prevents LV remodeling and improves clinical outcomes in STEMI patients compared with conservative strategies.
ST 段抬高型心肌梗死(STEMI)延迟就诊患者的最佳治疗策略仍不确定。
经皮冠状动脉介入治疗(PCI)对 STEMI 延迟就诊患者的左心室(LV)重塑和临床结局有有益影响。
选取 2009 年至 2011 年在中国 7 家具备 PCI 能力的医院住院的 STEMI 患者。2013 年 8 月至 2014 年 1 月期间通过超声心动图重新评估心脏特征。在中位随访期 36 个月期间评估临床终点。
分析了 1090 例接受延迟 PCI(n = 786)或仅接受标准药物治疗(n = 304)的患者。保守治疗组的左心室重塑更为明显。逻辑回归显示延迟 PCI 与左心室重塑独立且呈负相关(比值比:0.356,95%置信区间[CI]:0.251 - 0.505,P < 0.001)。Kaplan - Meier 分析显示延迟 PCI 组发生主要不良心血管事件(MACE)、全因死亡和因心力衰竭再次住院的风险较低。多因素 Cox 回归显示,在所有患者中(风险比[HR]:0.507,95%CI:0.412 - 0.625,P < 0.001;HR:0.419,95%CI:0.314 - 0.559,P < 0.001;HR:0.583,95%CI:0.379 - 0.896,P = 0.014)以及倾向评分分析匹配的患者中(HR:0.466,95%CI:0.358 - 0.607,P < 0.001;HR:0.398,95%CI:0.277 - 0.571,P < 0.001;HR:0.498,95%CI:0.283 - 0.878,P = 0.016),延迟 PCI 与 MACE、全因死亡和因心力衰竭再次住院的较低风险显著相关。
与保守策略相比,延迟 PCI 策略可预防 STEMI 患者的左心室重塑并改善临床结局。